Latest News

  • Golden Helix Looks Ahead After Receiving NIH Grant For Structural Variation Detection

    Diagnostics World | After announcing another grant from the National Institutes of Health to dig further into detecting structural variations, Golden Helix’s CEO and president discusses the company’s history, the shift in trajectory over the past five years, and what’s next.

    Oct 16, 2018
  • HCA Meets “Quadruple Aim” With AI-powered Cancer App

    Diagnostics World | HCA and Digital Reasoning have developed an AI-powered cancer app that reads pathology and radiology reports in real time, and then helps ensure care is rendered quickly and in the best prioritized order.

    Oct 9, 2018
  • Combining The Hive Mind With AI For Better Diagnoses

    Diagnostics World | A recent study, using technology developed by Unanimous AI, shows that a handful of doctors, connected by algorithms, achieved greater diagnostic accuracy for pneumonia than machine learning alone.

    Oct 3, 2018
  • Nobel Prize In Medicine Awarded To Two Cancer Researchers For Immune System Breakthrough

    STAT | The Nobel Prize in medicine was awarded to James Allison of MD Anderson Cancer Center and Tasuku Honjo of Kyoto University “for their discovery of cancer therapy by inhibition of negative immune regulation,” the Nobel committee announced.

    Oct 1, 2018
  • Rady Children’s Launches “Project Baby Bear”

    Diagnostics World News Brief | Rady Children’s Hospital-San Diego is launching Project Baby Bear, the first California State funded program to offer rapid whole genome sequencing for critically-ill newborns.

    Sep 27, 2018
  • uBiome, AliveCor, Ariel Precision Medicine, And More: News From September 2018

    Diagnostics World | September featured news, products, and partnerships from around the diagnostics community from numerous companies, universities, and organizations, including uBiome, AliveCor, Ariel Precision Medicine, and more.

    Sep 26, 2018
  • Proscia Closes $8.3M Series A Round Of Financing

    Diagnostics World News Brief | Proscia has closed an $8.3 million round of Series A financing from a group of East and West Coast venture capital firms. Proceeds from the financing will be used to expand the deployment of the company’s digital pathology software and accelerate the use of AI applications to drive accuracy and efficiency in cancer diagnosis.

    Sep 26, 2018